Information for healthcare professionals and the public about the COVID-19 Vaccine SKYCovion
The new COVID-19 vaccine from SK Chemicals, has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
The COVID-19 vaccine from Moderna has met the MHRA’s required safety, quality and effectiveness standards to be authorised for use in this age group
The offer of a first or second dose of COVID-19 vaccine will end on 30 June 2023 for most people.
Notification to GPs and NHS England that they should share information to support efforts against coronavirus (COVID-19).